STAT3 and non-small cell lung carcinoma: In another study, researchers found that BBI608, a small molecule STAT3 inhibitor known to inhibit cancer recurrence, progression, and metastasis, could suppress the expression of stemness-associated genes, deplete ALDH1-positive CSCs, and overcome cisplatin resistance in non-small cell lung cancer (NSCLC) [92].